Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute), 75922-75923 [2013-29745]

Download as PDF 75922 Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices We are also requesting a title change to read—Import Permit Applications (42 CFR 71.54). The Application for Permit to Import Biological Agents, Infectious Substances and Vectors of Human Disease into the United States form is used by laboratory facilities, such as those operated by government agencies, universities, and research institutions to request a permit for the importation of biological agents, infectious substances, or vectors of human disease. This form currently requests applicant and sender contact information; description of material for importation; facility isolation and containment information; and personnel qualifications. CDC plans to revise this application to request information on where the imported material will be stored at the recipient facility and who would be responsible for this location; verification that the permittee has implemented biosafety measures commensurate with the hazard posed by the infectious biological agent, infectious substance, and/or vector to be imported, and the level of risk given its intended use; and a secondary contact information for the permittee to provide in case the permittee is unavailable. These additional data requests will not affect the burden hours. The Application for Permit to Import or Transport Live Bats form is used by laboratory facilities such as those operated by government agencies, universities, research institutions, and for educational, exhibition or scientific purposes to request a permit for the importation, and any subsequent distribution after importation, of live bats. This form currently requests the applicant and sender contact information; a description and intended use of bats to be imported; and facility isolation and containment information. CDC plans to revise this application to request secondary contact information for the permittee to provide in case the permittee is unavailable. These additional data requests will not affect the burden hours. Estimates of burden for the survey are based on information obtained from the CDC import permit database based on the number of permits issued on annual basis since 2010. The total estimated annual burden for the data collection is 545 hours. We estimate a decrease in the number of respondents from 2,000 in 2011 to 1,625 due to recent trends and changes in the regulation. The daily operations have observed a decrease in the number of request for an import permit since 2011. In addition, the changes in 42 CFR 71.54, which became effective April 5, 2013, specify situations where an application for a permit is no longer required. For example, the importation of a select agent that is regulated under 42 CFR Part 73 no longer requires a permit be issued. There are no costs to respondents except their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name Applicants Requesting to Import Biological Agents, Infectious Substances and Vectors. Applicants Requesting to Import Live Bats .... Application for Permit to Import Infectious Biological Agents into the United States. Application for a Permit to Import Live Bats .. LeRoy Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–29742 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention ehiers on DSK2VPTVN1PROD with NOTICES Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH or Institute) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:00 a.m.–5:00 p.m., February 19, 2014 (Closed) 8:00 a.m.–5:00 p.m., February 20, 2014 (Closed) VerDate Mar<15>2010 13:32 Dec 12, 2013 Jkt 232001 8:00 a.m.–5:00 p.m., February 21, 2014 (Closed) Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314, Telephone: (703) 684–5900, Fax: (703) 684–0653. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broad-based research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters to Be Discussed: The meeting will convene to address matters related PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hrs.) 1,625 1 20/60 10 1 20/60 to the conduct of Study Section business and for the study section to consider safety and occupational healthrelated grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, Centers for Disease Control and Prevention, pursuant to Section 10(d) Public Law 92–463. Agenda items are subject to change as priorities dictate. Contact Person For More Information: Price Connor, Ph.D., NIOSH Health Scientist, CDC, 2400 Executive Parkway, Mailstop E–20, Atlanta, Georgia 30345, Telephone: (404) 498–2511, Fax: (404) 498–2571. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and E:\FR\FM\13DEN1.SGM 13DEN1 Federal Register / Vol. 78, No. 240 / Friday, December 13, 2013 / Notices Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29745 Filed 12–12–13; 8:45 am] [FR Doc. 2013–29750 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review ehiers on DSK2VPTVN1PROD with NOTICES Prevention and the Agency for Toxic Substances and Disease Registry. Advisory Committee on Breast Cancer in Young Women (ACBCYW) The meeting announced below concerns Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, Funding Opportunity Announcement (FOA) CK14–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time And Date: 1:00 p.m.–3:00 p.m., February 18, 2014 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monkeypox in Tshuapa District, Democratic Republic of the Congo, FOA CK14–002’’. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718– 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Mar<15>2010 13:32 Dec 12, 2013 Jkt 232001 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–3:00 p.m. EST, January 9, 2014. Place: The meeting will be held via Teleconference. Limited teleconference access is also available. Teleconference login information is as follows: For Public: TOLL–FREE PHONE #: 888–989–8135 Participant passcode: BREASTCANCER or 273278226237 For Public: Net Conference URL: https://www.my meetings.com/nc/join/ Conference number: PW3233834 Audience passcode: BREASTCANCER or Public can join the event directly at: https://www.mymeetings.com/nc/join. php?i=PW3233834&p=BREAST CANCER&t=c. There is also a toll free number for anyone outside of the USA: TOLL #: 1– 203–827–7034. Participant passcode: BREASTCANCER or 273278226237. Status: Open to the public, limited only by the net conference and audio phone lines available. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and PO 00000 Frm 00014 Fmt 4703 Sfmt 4703 75923 dissemination of credible appropriate messages and resource materials. Matters To Be Discussed: The agenda will include discussions on the current and emerging topics related to breast cancer in young women. These may include risk communication and health education, as well as approaches to increase awareness of clinicians/ practitioners regarding topics such as breast cancer risk, breast health, symptoms, diagnosis, and treatment of breast cancer in young women. Agenda items are subject to change as priorities dictate. Online Registration Required: All ACBCYW Meeting participants must register for the meeting online at least 5 days in advance at http://www.cdc.gov/ cancer/breast/what_cdc_is_doing/ meetings.htm. Please complete all the required fields before submitting your registration and submit no later than January 5, 2014. Contact Person For More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia 30341, Telephone (770) 488–4518, Fax (770) 488–4760 Email: acbcyw@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–29749 Filed 12–12–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) Office for State, Tribal, Local and Territorial Support (OSTLTS) In accordance with Presidential Executive Order No. 13175, November 6, 2000, and the Presidential Memorandum of November 5, 2009, and September 23, 2004, Consultation and Coordination with Indian Tribal Governments, CDC/Agency for Toxic Substances and Disease Registry (ATSDR), announces the following meeting and Tribal Consultation Session: E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 78, Number 240 (Friday, December 13, 2013)]
[Notices]
[Pages 75922-75923]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29745]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Safety and Occupational Health Study Section (SOHSS), National 
Institute for Occupational Safety and Health (NIOSH or Institute)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:
    Times and Dates:
8:00 a.m.-5:00 p.m., February 19, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 20, 2014 (Closed)
8:00 a.m.-5:00 p.m., February 21, 2014 (Closed)
    Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 
22314, Telephone: (703) 684-5900, Fax: (703) 684-0653.
    Purpose: The Safety and Occupational Health Study Section will 
review, discuss, and evaluate grant application(s) received in response 
to the Institute's standard grants review and funding cycles pertaining 
to research issues in occupational safety and health, and allied areas.
    It is the intent of NIOSH to support broad-based research endeavors 
in keeping with the Institute's program goals. This will lead to 
improved understanding and appreciation for the magnitude of the 
aggregate health burden associated with occupational injuries and 
illnesses, as well as to support more focused research projects, which 
will lead to improvements in the delivery of occupational safety and 
health services, and the prevention of work-related injury and illness. 
It is anticipated that research funded will promote these program 
goals.
    Matters to Be Discussed: The meeting will convene to address 
matters related to the conduct of Study Section business and for the 
study section to consider safety and occupational health-related grant 
applications.
    These portions of the meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, Centers for Disease Control and 
Prevention, pursuant to Section 10(d) Public Law 92-463.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Price Connor, Ph.D., NIOSH 
Health Scientist, CDC, 2400 Executive Parkway, Mailstop E-20, Atlanta, 
Georgia 30345, Telephone: (404) 498-2511, Fax: (404) 498-2571.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and

[[Page 75923]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-29745 Filed 12-12-13; 8:45 am]
BILLING CODE 4163-18-P